Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 237.59 M240.79 M248.8 M256.58 M 983.76 M Research & development 74.59 M76.11 M78.45 M87.07 M 316.22 M Operating income 162.09 M191.29 M286.01 M135.79 M 775.19 M Non-Operating Income, Total 769 K-168 K2.34 M5.38 M 8.32 M Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -393 K-104 K206 K5.53 M 5.24 M Unusual income/expense 1.16 M-64 K2.13 M-150 K 3.08 M Pretax income 174.49 M203.06 M299.13 M149.85 M 826.52 M Equity in earnings ———— — Taxes 28.47 M32.38 M48.09 M6.39 M 115.33 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 146.01 M170.67 M251.04 M143.46 M 711.19 M Discontinued operations ———— — Net income 146.01 M170.67 M251.04 M143.46 M 711.19 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 146.01 M170.67 M251.04 M143.46 M 711.19 M Basic earnings per share (Basic EPS) 0.991.161.710.99 4.85 Diluted earnings per share (Diluted EPS) 0.981.151.690.98 4.8 Average basic shares outstanding 147.86 M147.12 M146.83 M146.78 M — Diluted shares outstanding 149.05 M148.42 M148.45 M148.21 M — EBITDA 850.69 M887.56 M1.12 B767.87 M 3.63 B EBIT 830.84 M862.89 M1.09 B738.04 M 3.52 B Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 19.86 M24.67 M27.97 M29.83 M 102.33 M